foxo4-dri senolytic mouse 2023 2024

foxo4-dri senolytic mouse 2023 2024 Frontiers FOXO4-DRI: Human Trial Status, Cancer

Name: foxo4-dri senolytic mouse 2023 2024 Frontiers FOXO4-DRI: Human Trial Status, Cancer
Brand: iglepidom.org
SKU: 43274943843
Price: 20.96 USD
Availability: InStock
Rating: 4.8883 (14 reviews)

FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv ES2 disrupts FOXO4 foci and localizes to FOXO4 foci. a, Representative Download Scientific Diagram Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine

SKU: 43274943843 · From iglepidom.org

4.9

USD20.96 USD57.96

Pay in 4 interest-free payments of $5.24 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 10 - Aug 15

Description

Although interest is growing, it is important to understand that BPC-157 is still being researched, and use should only occur under the guidance of a qualified medical provider

In preclinical studies, it inhibited proliferation of a broad range of tumor cell lines (cell IC50 6.2 nM to 4.3 M) and inhibited HUVEC growth in response to HGF and VEGF as an in vitro model of angiogenesis [116]